Large Cap High Growth Potential

Results

261

15 new

Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.

261 companies

	Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield	Industry
	MOD	US$247.09	7.6%	163.3%	US$12.1b	US$340.86	108.0	49.2%	n/a	Capital Goods
	CRDO	US$223.87	-5.2%	140.9%	US$39.5b	US$279.29	88.4	27.7%	n/a	Semiconductors
	NVDA	US$207.29	-2.1%	24.1%	US$4.9t	US$302.83	31.5	22.8%	0.5%	Semiconductors
	SPCX	US$123.54	-9.2%	n/a	US$1.6t	US$240.04	84.3	60.7%	n/a	Telecom
	GH	US$152.29	-4.9%	229.3%	US$19.6b	US$171.08	18.7	55.8%	n/a	Healthcare
	LITE	US$837.56	2.8%	740.7%	US$59.6b	US$1,104.89	148.4	56.5%	n/a	Tech
	MDGL	US$546.79	1.8%	74.5%	US$12.4b	US$678.86	11.1	59.7%	n/a	Pharmaceuticals & Biotech
	AXSM	US$236.95	0.7%	131.1%	US$11.4b	US$282.51	17.2	57.0%	n/a	Pharmaceuticals & Biotech
	NU	US$14.39	2.9%	12.5%	US$68.0b	US$17.94	5.6	20.1%	n/a	Banks
	MRVL	US$207.96	-6.5%	188.9%	US$170.7b	US$254.41	72.1	26.2%	0.1%	Semiconductors
	ARM	US$289.73	3.0%	85.1%	US$288.0b	US$302.35	342.3	37.0%	n/a	Semiconductors
	SMTC	US$137.84	-2.5%	167.8%	US$11.7b	US$205.25	11.8	74.6%	n/a	Semiconductors
	BE	US$226.26	-7.0%	772.6%	US$56.1b	US$286.20	10667.7	45.5%	n/a	Capital Goods
	AMD	US$544.43	-0.7%	251.9%	US$821.1b	US$541.66	180.0	36.3%	n/a	Semiconductors
	MTSI	US$283.03	-6.2%	107.0%	US$20.6b	US$400.92	122.2	34.3%	n/a	Semiconductors
	RDDT	US$185.84	-8.6%	27.5%	US$35.0b	US$227.30	50.6	25.3%	n/a	Media
	CBRS	US$208.57	2.3%	n/a	US$40.1b	US$291.09	483.4	73.7%	n/a	Semiconductors
	ALAB	US$319.79	-11.6%	173.5%	US$53.0b	US$297.01	204.8	31.8%	n/a	Semiconductors
	FN	US$527.35	9.2%	75.3%	US$17.7b	US$749.11	44.9	22.3%	n/a	Tech
	APP	US$428.69	-4.5%	22.5%	US$142.6b	US$654.60	36.8	21.7%	n/a	Software
	LSCC	US$135.83	1.4%	158.7%	US$17.2b	US$148.33	936.2	60.0%	n/a	Semiconductors
	AVGO	US$386.50	-0.7%	38.7%	US$1.8t	US$525.44	62.7	33.5%	0.7%	Semiconductors
	AXON	US$511.17	-6.6%	-29.1%	US$42.5b	US$660.88	200.0	22.7%	n/a	Capital Goods
	KRYS	US$339.06	-0.1%	123.2%	US$10.0b	US$361.67	44.4	35.8%	n/a	Pharmaceuticals & Biotech

Page 1 of 8